PACAP (pituitary adenylate cyclase-activating polypeptide) is a member of the VIP/secretin/glucagon family, which includes the ligands of class II G-protein coupled receptors. Since the recognition of PACAP by the receptor may involve the binding of PACAP to membranes, its membrane-bound structure should be important. We have carried out structural analysis of uniformly 13 C, 15 N labeled PACAP27 and its C-terminal truncated form PACAP(1-21)NH 2 (PACAP21) bound to membranes with high resolution solid-state NMR. Phosphatidylcholine bilayers and phosphatidylcholine/phosphatidylglycerol bilayers were used for PACAP27 and PACAP21, respectively. Most backbone signals were assigned for PACAP27 and PACAP21. TALOS analysis revealed that both peptides take on extended conformations on the membranes. Dilution of PACAP21 did not change the conformation of the major part. Selective polarization transfer experiment confirmed that PACAP27 is interacting with the membranes. It was concluded that the interaction of PACAP with the membrane surface causes their extended conformation. PACAP27 is reported to take an α-helical conformation in dodecylphosphocholine micelles and membrane-binding peptides usually take similar conformations in micelles and in membranes. Therefore, the property of PACAP27 changing its conformation in response to its environment is unique. Its conformational flexibility may be associated with its wide variety of functions.
Introduction
PACAP (pituitary adenylate cyclase-activating polypeptide) is a hormone peptide classified into VIP/secretin/glucagon family, which are ligands of class II G-protein coupled receptors. This peptide was first isolated from ovine hypothalamus, which directly stimulates the release of several pituitary hormones. Two forms of PACAP, which are composed of 27 and 38 amino acid residues, have been found, and are called PACAP27 and PACAP38, respectively. The amino acid sequence of the former is identical to that of the N-terminal 27 residues of the latter. PACAP is evolutionally conserved in vertebrates. The primary structure of PACAP38 has been totally conserved among human [1] , sheep [2] , rat [3] , and mouse [4] . The sequences of PACAP38 and PACAP27 are shown below along with a C-terminal truncated derivative, PACAP21.
Oncorhynchus nerka [7] , catfish Clarias macrocephalus [8] and tunicate Chelyosoma productum [9] . There is 96% sequence identity between human and tunicate PACAP27 [9] . These facts suggest that there have been a high evolutionary pressure to conserve the PACAP sequence.
In view of the sequence homology, the mechanism underlying the binding of PACAP to its receptor should be fundamentally conserved as well. The PACAP receptors are classified into 3 subtypes, i.e. PAC1, VPAC1 and VPAC2. PAC1 is involved in several neurotransduction systems, and is found in brain areas, including the hypothalamus. Therefore, PACAP might be working as neurotransmitter/neuromodulator and hypophysiotropic neurohormone regulator [10] [11] [12] . PACAP receptors are located not only in the brain, but also in peripheral tissues. VPAC1 and VPAC2, which serve as high affinity receptors for both PACAP and VIP, are primarily coupled with adenylate cyclase in the human muscle, heart, lung, kidney, stomach, testis, pancreas, and liver. This peptide acts as a blood pressure depressor [13] , a smooth muscle relaxing factor [14] , a promotion factor of insulin release from the pancreatic β-cell, and so on [15] . Thus, PACAP plays important roles in various physiological regulation systems.
The tertiary structures of PACAP21 bound to the PAC1 receptor and PACAP27 in dodecylphosphocholine (DPC) micelles were determined by transferred nuclear Overhauser effect (trNOE) and steady-state NOE, respectively [16] . The structure of micelle-bound PACAP27 comprises a long α-helix (residues 5-27) flanked by a disordered N-terminal tail (residues 1-4). In the case of the receptor-bound PACAP21 structure, however, an extended N-terminal tail (residues 1-2) is followed by consecutive β-turns (residues 3-7) and an α-helix (residues 8-21). A two-step model for the ligand targeting to the receptor through the membrane surface was proposed on the basis of the obtained conformations. Recently, the solution structure of N-terminally truncated PACAP38 (residue binding to the extracellular domain of the PAC1 receptor was determined by NMR [17] . The peptide takes on a curved α-helix in the receptor.
Since the recognition of PACAP by the receptor and the following signal transduction take place in the membrane systems and a model for the recognition mechanism involves membrane-binding of PACAP, it is important to know the conformations of PACAP27 bound to membranes. For the analysis of the membrane-bound peptide, solid-state NMR is one of the most suitable methods. We have actually shown that this is a promising method through the structural analysis of a G-protein activating peptide, mastoparan X [18, 19] and H + -ATPsynthase subunit c [20] . Conformational studies of other membrane-bound peptides have been reported as well [21] . The results reported so far have revealed that many of them take on α-helices in their major parts. Usually, it is not easy to obtain uniformly isotope labeled peptides for NMR analysis. We have developed an efficient expression system for PACAP peptides. Then, the structural analysis of membrane-bound PACAP peptides by solid-state CP/MAS NMR has been carried out in this work. The result has shown that the conformations of the membrane-bound peptides are different from that of the micellebound one and PACAP peptides assume different conformations depending on the interacting partners.
Materials and methods

Peptide expression and purification
A pET21b vector was used to clone a gene of the fusion protein of thioredoxin (Trx) and PACAP21-Gly or PACAP27-Gly with an N-terminal 6His-tag [22] . It was introduced into competent Escherichia coli (E. coli) BL21 (DE3) (Novagen, Madison, WI, USA) and expressed under the control of lac promoter. A single colony was inoculated into 5 ml of LB medium containing ampicillin (50 μg/ml) and it was incubated for 3-5 h at 37°C. When OD 660 became 0.5, 1 ml of the culture was inoculated into 500 ml of CHL medium (CHLORELLA Industry Co., Tokyo, Japan) with ampicillin (50 μg/ml) in a 2-l baffled flask, which was incubated for about 4 h at 37°C with a shaking rate at 120 rpm. At 0.2 OD 660, the temperature was adjusted to 30°C. At 0.5 OD 660 , isopropylthio-β-D-galactoside (IPTG) was added (final 0.8 mM) for induction. The cells were further incubated for 6 h (up to about 1 OD 660 ) and harvested. The cell suspension was sonicated for 10 min (2 min interval per min) at 4°C and was centrifuged for 20 min at 20000 rpm. The supernatant was applied to a DEAE column. Then, the fusion protein was purified by Ni-NTA superflow (Qiagen, Valencia, CA, USA) affinity column chromatography at 4°C and was concentrated. For isotope-labeling, 1 ml culture at OD 660 = 0.5 was centrifuged at 6000 rpm. The pellet was suspended with 0.1 ml of a 0.9% NaCl solution, and added to 500 ml of a 13 C, 15 N labeled CHL medium.
For cleavage of the fusion protein, Factor Xa (New England Biolabs, Beverly, MA, USA) was added at 0.25% (w/w) of the substrate in a 100 mM NaCl, 50 mM Tris-HCl buffer, pH 7.4. The substrate concentration was about 0.6 mM. The reaction mixture was incubated for 3 h at 4°C. The Factor Xa was removed with a Sep-Pak C18 environmental cartridge (Waters, Milford, MA, USA). The PACAP21-Gly or PACAP27-Gly was eluted with acetonitrile solution (50-70%) containing 0.05% (v/v) TFA, then purified by reverse-phase HPLC (Gilson, Middleton, WI, USA) with a Wakosil 5C18 column (Wako Pure Chemical Industries, Ltd, Osaka, Japan) and a linear water/acetonitrile gradient containing 0.05% TFA.
C-terminal amidation of the obtained peptide was achieved by the oxidation of its terminal Gly residue with peptidylglycine α-amidating enzyme [23] . The purified PACAP was obtained with the HPLC again. The purities of these peptides were confirmed by Tricine-SDS-PAGE and mass spectrometry using a matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometer (Autoflex, Bruker Daltonics, Germany). Peptidylglycine amidating monoxygenase was purchased from Wako Pure Chemical Industries, Ltd (Japan).
Preparation of membrane-bound peptides
Multilamellar liposomes were prepared by a freeze-and-thaw treatment. For PACAP21, deuterated 1,2-dipalmitoyl-sn-glycero-3-phosphocholine-d 62 (DPPC, 98% 2 H) and deuterated 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol-d 62 (DPPG, 98% 2 H) were used to prepare liposomes. They were dissolved in chloroform/methanol (1:1, v/v), and then the solution was dried to a film by evaporator. The ratio of DPPC to DPPG was 4 to 1 (mol/mol). It was further dried under high vacuum to remove all trace of organic solvent. The dried film was suspended in ultrapure water. The final concentration of the suspension was 10 mg/ml. The lipid suspension was subjected to typically ten freeze/thaw cycles. For PACAP27, deuterated 1,2-dimyristoyl-sn-glycero-3-phosphocholine-d 54 (DMPC, 98% 2 H) was used as the phospholipid. Then, the peptide was added to the liposome suspension (lipid/PACAP21 = 36 and 360, and lipid/ PACAP27 = 20 mol/mol), followed by about ten freeze/thaw cycles. The supernatant was removed by centrifugation at 30000 g for 30 [24] . Lee-Goldburg cross-polarization experiment [25] , twodimensional 13 C homonuclear correlation experiment RFDR [26, 27] , SPC-5 [28] and DARR [29, 30] were recorded with standard pulse sequences. Cβ) i+1 experiment were performed using reported pulse sequences [18] . The initial magnetization was prepared by cross polarization from the proton magnetization with a contact time of 2 ms and the RF field amplitude was ramped near the first sideband for the Hartmann-Hahn condition, γB N- 13 C correlation experiments [31, 32] . Data matrix (512 (t1) × 1024 (t2), unless otherwise mentioned) was zerofilled to 1024 × 1024, multiplied by an exponential window function with a 100 Hz broadening factor, and analyzed with the aid of Felix version 2002 (Accelrys Inc., San Diego, CA USA). All two-dimensional spectra were presented by the contours with S/NN3.0 except for otherwise specified. 13 C and 15 N chemical shift values were referenced to 2,2-dimethylsilapenatane-5-sulfonic acid (DSS) [33] . 
Results
Signal assignment of PC/PG-membrane bound PACAP21
Since PACAP21 did not bind to PC bilayers, DPPC/DPPG bilayers were used as membranes. To suppress the background signals from the lipids, deuterated DPPC-d 62 and DPPG-d 62 were used for sample preparation. The assignment of the signals was carried out as follows. At first, the type of amino acid was determined, using intra-residual 13 C, 13 C-and 13 C, 15 N-correlation spectra. The sequential number can be identified for single residues in the peptide at this stage. Then, the sequential assignment was performed using inter-residual 13 C i , 15 N i+1 -and 13 C i , 13 C i+1 -correlation 2D NMR spectra. Here, some of the signals were unequivocally assigned. Then, the overlapped signals were tentatively assigned using bulk chemical shifts determined at the first step, assuming the presence of all signals.
A 2D homonuclear 13 C-13 C correlation DARR spectrum of the membrane-bound PACAP21 (lipid/peptide = 36) is presented in Fig. 1 . Assignment started with the BMRB database that gives the typical chemical shifts of amino acid residues. As shown in Fig. 1D , aliphatic carbon spin systems of Ile5, Thr7 and Val19 could be traced. Here, the numbered residues are uniquely assigned because they are single residues in PACAP21. Using the information from 13 C i , 15 N i -correlation in Fig. 2A , the spin systems of Arg and Lys were also traced. The Cα/Cβ cross peaks for Ala18 and Ser could be easily identified at (51, 23) and (56, 66) ppm. However, the signals of three Ser residues could not be observed separately. This is a typical feature of the spectra obtained in this work. We can get only bulk chemical shifts for each amino acid residue in an intra-residue correlation spectrum. The Cβ chemical shifts of Phe, Tyr and His were determined by Cβ/Cγ cross peaks (Fig. 1C) . The Gly4 Cα/C', Ala18 Cβ/C' and Ser Cα/C' cross peaks could be also assigned in Fig. 1A . Signals at the lowest field could be assigned to the side chain carboxyl groups of Asp and carboxylamide groups of Gln16 and Lys21. Otherwise, the carbonyl signals were assumed to be located at overlapped peaks in Cβ/C' areas. This is reasonable because of their narrow distributions. The cross peaks of Cζ/Cδ, Cζ/Cγ, Cζ/Cβ and Cζ/Cα of Arg were identified at (160, 44), (160, 28), (160, 35) and (160, 54) ppm in a DARR spectrum with 200 ms mixing time as can be seen in Fig. 1B . There are contributions from Tyr to the signals at 44 and 54 ppm as well.
2D heteronuclear 15 N-13 C spectra for intra-and interresidue correlations ( 15 N i -13 (CαCβ) i and 15 N i+1 -13 (CO, CαCβ) i , respectively) are presented in Fig. 2 . From the intraresidue correlation ( Fig. 2A) (Fig. 2B ), D3CαG4N could be identified as an isolated peak. Possible assignments are also presented in the figure on the basis of the assignment of 13 Cα, namely, I5αF6N, T7αD8N, V19αK20N and A18αV19N in the major body of overlapping, and G4αI5N and I5βF8N in the neighbor.
A Cα i+1 -(CαCβ) i correlation spectrum of PACAP21 is shown in Fig. 3 . We could assign well resolved (CαCβ) i+1 -Cα i cross peaks to I5αF6α and M17αA18α correlation signals on the basis of assigned chemical shifts for Ile5 Cα, Phe6 Cα and Ala18 Cα. Therefore, Met17 Cα/Cβ should be located in the congested region at around (54, 35) ppm. Since Cβ of Gln appears at the highest field except for that of Ala and the chemical shift of Met17Cα is known, the cross peak at (30, 54) ppm was attributed to Q16βM17α. Although the Cα i+1 -Cα i correlations for D3G4, G4I5, F6T7, A18V19 and V19K20 should appear as isolated or well-defined peaks, they failed to emerge. These cross peaks could not be observed even in lower contour levels. The assigned chemical shifts are summarized in Table 1 . Signals only assigned to individual amino acids are shown in italics and the assignment of a signal overlapped with those of other amino acids is given in a parenthesis. The uncertainty due to the line-width is given for Cα, Cβ and C′ in the table.
Since we used a sample at a high peptide concentration, the effect of concentration on the chemical shifts was examined with a 10-fold diluted sample (lipid/peptide = 360). 2D spectra could not be obtained with this sample. Thus, 1D MAS/CP 13 C-NMR spectra were recoded for the samples at high and low peptide concentrations. They are compared in Fig. 4 . On 
Signal assignment of PC membrane-bound PACAP27
Since PACAP27 binds to DMPC bilayers, we prepared the sample with deuterated DMPC-d 54 . This sample gave a better RFDR spectrum at 233 K and a better SPC-5 spectrum at 273 K. RFDR spectra gave the information essentially identical with that from SPC-5 spectra.
13 C-13 C correlation spectra of membrane-bound PACAP27 are presented in Fig. 5 . The observed chemical shifts were the same within the resolution limits at temperature from 213 to 273 K. Under these conditions, the DMPC bilayers are in the gel state. In the double quantum dipolar mixing spectrum, one-step magnetization transfer gave rise to a negative intensity, colored green, and two-step magnetization transfer gave rise to a positive intensity, colored black. Spin connectivities of Ile, Thr, Val, Leu, and Arg could be traced as shown in the spectrum (Fig. 5C ). Although there are two Leu Cα/Cβ cross peaks, they will be justified by later assignment. Those of Arg, Lys, and Gln16 also could be traced in the DARR spectrum (Fig. 5D ). In the case of Arg and Lys, the chemical shifts determined by 13 C, 15 N-correlation ( some of their chemical shifts could be determined separately as will be described later. The Cβ chemical shifts of Phe, Tyr and His are determined using their Cβ/Cγ cross peaks (Fig. 5B) . His1 Cβ/Cγ was very weak. In the case of Tyr, however, two Cα/Cβ cross peaks were assigned. At first, it was assigned to (56, 43) ppm from the major intensity of the Cβ/Cγ cross peak as in the case of Phe6. Since a weak cross peak at (53, 41) ppm was remained unassigned at the final stage of the assignment, this was tentatively assigned to Tyr in view of the Cβ chemical shift. In Fig. 5A , Gly4 Cα/C', Ala Cβ/C', Thr7 Cβ/C', Ser Cβ/C', Ile5 Cα/C' and Val Cα/C' could be assigned. Furthermore, signals at the lowest field could be assigned to the side chain carboxyl groups of Asp and carboxylamide groups of Gln16 and Leu27. Otherwise, the peak tops were interpreted as the overlapped carbonyl signals in Cβ/C' areas as in the case of PACAP21.
A 2D intra-residue 15 N-13 C correlation spectrum of PACAP27 is presented in Fig. 6A . The 15 N chemical shifts can be specified from the 13 C chemical shifts of isolated cross peaks. The His1 Cα/N, Gly4 Cα/N, Ala Cβ/N, Lys Cε/Nζ, Lys Cδ/Nζ, Arg Cδ/Nε and Arg Cγ/Nε cross peaks could be easily identified. His1 signal was observed as two peaks, suggesting that the N-terminus takes two conformations. On the basis of the carbon chemical shifts, Val Cα/N could be assigned as well. The inter-residue 15 N i+1 -13 (CO, CαCβ) i correlation spectrum (Fig. 6B ) provides more information. The cross peaks of D3Cα/G4N, D3Cβ/G4N and L27C'/NH 2 could be easily assigned because of well-distinguished 15 N chemical shifts. In the Ala cross peak, there are evidently two kinds of signals, which were assigned to two A i Cβ/V i+1 N and A24Cβ/A25N, respectively, on the basis of their intensity. Otherwise, indicated in the spectrum are the cross peaks that were assigned on the basis of carbon and nitrogen chemical shifts so far obtained.
A Cα i+1 -Cα i correlation spectrum of the membrane-bound PACAP27 shown in Fig. 7 provided further information for Cα. In contrast to PACAP21, isolated and peripheral cross peaks are well defined except for D3G4. Thus, we can make a sequential walking using the chemical shifts assigned so far. In the N-terminal region, the walking starts from well-defined cross peaks, namely, G4/I5, F6/T7, and T7/D8. I5/F6 can be identified from G4/I5 and F6/T7. Since we know the chemical shifts of His1 and Asp3, the walking can be extended to the N-terminus by use of the bulk chemical shift of Ser. The cross peak M17/A18 can be assigned on the basis of Ala chemical shift as in the case of PACAP21. Since the chemical shift of Gln16 is known, we can walk from Gln16 to the C-terminus on the basis of the well-defined cross-peaks, A18/V19, V19/K20, L23/A24, A24/A25, A25/V26, and V26/L27, provided that the chemical shifts of Lys21 and Tyr22 are known. Note that the chemical shifts of Lys20 and Ala25 are different from the bulk value of each amino acid residue, respectively. There are two possibilities for Tyr22, namely, 53 and 56 ppm. In the case of the former, Y22/L23 should appear on the diagonal line. Since there is no signal intensity in the expected region in Fig. 7 , the chemical shift of Tyr22 was assigned to 56 ppm. The bulk shift (55 ppm) was used for Lys21. From Ser9 to Lys15, the walking was carried out using bulk chemical shifts of Ser, Lys and Arg because of serious overlapping of the cross peaks. There are two possibilities for Tyr residues as in the case of Tyr22. If Tyr10 is assigned to 53 ppm, the intensity in the central region cannot be explained. In contrast, Tyr13 fits to 53 ppm. Therefore, Tyr10 and Tyr13 are assigned to 56 and 53 ppm, respectively. Now, the walking from the N-to C-termini is accomplished. This walking not only confirm the observed chemical shifts, but also provided more exact chemical shifts for some signals. Assigned chemical shifts of PACAP27 are summarized in Table 2 in the same way as for PACAP21.
Selective polarization transfer from PACAP to membranes
To confirm the binding of the PACAP peptide to phospholipid membranes, the polarization transfer from the proton spins of the PACAP27 to 2 H/ 31 P one of membranes was measured. COXSHD spectra of the membrane-bound PACAP27 for 1 H-31 P and 1 H-2 H transfer are presented in Fig. 8A and B, respectively. To make the cross polarization efficient, the measurement was carried out at 193 K. In Fig. 8A , the polarization transfer was observed for Tyr, Phe, His, Ser Cβ, Thr Cβ, some of Cα and side chains of Ile, Leu, Asp, Lys and Arg. This reveals that PACAP27 actually binds to phospholipid bilayers. Since phosphate groups are located on the surface of phospholipid membranes, the peptide should lay on the membrane surface. The polarization transfer from the protons to the deuterons of fatty acids provides the information about the amino acid residues interacting with the hydrophobic region of the membrane. In Fig. 8B , the transfer was also observed for aliphatic carbons and aromatic carbons. However, the pattern is different from that in Fig. 8A . Especially, the transfer was mainly observed for Phe in the aromatic region, judged from the weak HY signal. This indicates that the side chain of Phe is inserted into the hydrophobic region, while those of His and Tyr stay in the surface region. In the aliphatic region, the polarization was observed mainly for Cβ and Cγ of Ile, Leu and Val, and Cβ of Ala and Phe. This fact shows that PACAP27 is localized on the membrane surface with the hydrophobic side chains being inserted into the inner region of the membrane. Since Ala, Leu and Val are the residues in the C-terminal region of PACAP27, the C-terminal hydrophobic region plays an important role in binding to the membrane.
Discussion
Secondary structural analysis of PACAP21 and PACAP27
The spectral sensitivity and resolution was better for PACAP27 than for PACAP21, which may be attributed to differences in the phospholipid composition and the rotor size. Because of broad line-widths, the sequentially assigned signals were 10/21Cα, 8/20Cβ and 3/21C' for PACAP21, and 17/27Cα, Italics, assignment to individual amino acid species; [ ], assignment for the signal overlapped with those of other amino acid species. 11/26Cβ and 3/27C' for PACAP27. However, the uncertainty was within ± 2 ppm for most signals. For isolated peaks of single residues, the line-width is 2-3 ppm. Since the contribution of line-broadening factor is 0.8 ppm, the intrinsic line-width should be 1.2-2.2 ppm. The 13 C linewidth of 1.5-2 ppm at 11.74 was reported to be a typically well-structured and rigid noncrystalline peptide, while a disordered structure gives a 4-5 ppm [35] . Therefore, PACAP21 and PACAP27 should take a relatively well-defined structure.
We have calculated the main chain φ and ψ angles with the program TALOS version 2003.027.13.05, using 13 Cα, 13 Cβ, and 13 C' chemical shifts [36] . Predicted φ and ψ angles are plotted in red in Fig. 9 . The classification was "good" for all residues except Gly4. In view of the broad line-widths, the effect of the uncertainty on the prediction of dihedral angles was checked. The dihedral angles were calculated for the chemical shifts δα i + Δδα i and δβ i − Δδβ i , where Δδ is the uncertainty shown in Tables 1 and 2 . This gives the largest change favorable for a helical conformation. Nevertheless, the obtained angles are favorable for extended conformations in spite of two unreliable angle pairs (Fig. 9, in green) . Calculations for the chemical shifts δα i − Δδα i and δβ i + Δδβ i were also carried out, which gave the angles favorable for extended conformations (Fig. 9, in  blue) . This result indicates that backbone dihedral angles of membrane-bound PACAP21 and PACAP27 fit to extended conformations. Then, the chemical shifts were calculated for all extended conformations with SHIFTX. They matched the observed chemical shifts except Gly4. Therefore, we have concluded that both PACAP21 and PACAP27 take on the extended conformation on binding to lipid membranes in the gel state, although there could be a distortion around Gly4.
Comparison of the obtained conformations with those of PACAP27 in micelles and PACAP21 bound to the receptor
The reported structure of the DPC micelle-bound PACAP27 comprises a long α-helix (residues 5-27) flanked by a disordered N-terminal tail (residues 1-4) [16] . This is different from the extended conformation of the membrane-bound PACAP27 determined in this work. Therefore, carbon chemical shifts were calculated with SHIFTX [37] for all α-helix structure of PACAP27 and mapped on a 13 C-13 C correlation spectrum of DMPC membrane-bound PACAP27. The calculated cross peaks did not match the observed one (data not shown), confirming that the secondary structure of membrane-bound PACAP27 is different from the conformation in DPC micelles.
A 2D 13 C-13 C DARR spectrum of PACAP21 with a mixing time 500 ms was observed to detect relatively long-range distances (∼ 6.5 Å). It is presented in Fig. 10 . A well-separated peak at (46, 60) ppm could be assigned to either G4Cα/T7Cα or G4Cα/V19Cα correlation. One possibility is that G4T7 correlation is caused by bending of peptide as in the case of the receptor-bound PACAP21 [16] . However, the predicted dihedral angles in Fig. 9 contradict this idea. So, this correlation should be originated from the inter-chain distance. If the peptide region of His1-Tyr10 takes on an antiparallel β-sheet that brings Gly4 and Thr7 close to each other, Asp3 and Asp8 line up side by side. This would be unstable on the membranes with net negative charges. Therefore, a possible structure is an antiparallel β-sheet formed by the peptide region from Ser2 to Lys21 that brings Gly4 and Val19 close to each other.
Conformational characteristics of PACAP27 and PACAP21 bound to the membranes
Although the overall conformation is the same for PACAP21 and PACAP27, the binding mechanism is different. While the former cannot bind to PC membranes, the latter can. The side chains of the hydrophobic residues of PACAP27 were shown to be involved in the binding. Therefore, the nature of the binding for the former and latter should be electrostatic and hydrophobic interactions, respectively. In the measurement of Cα i+1 -(CαCβ) i correlation of PACAP21, the cross peaks of D3G4, G4I5, F6T7, A18V19 and V19K20 could not be observed in the expected regions. Although we do not have the information on H1S2 and S2D3 because of their localization in the congested region, it is strongly suggested that the N-terminal region is relatively flexible even at 223 K because of the soft interaction on the membrane surface. Since the pulse sequence of the Cα i+1 -(CαCβ) i correlation includes three cross polarizations, mobility makes the total polarization transfer inefficient. Since D3G4 cross peak could not be observed and the intensity of G4I5 was very weak, the N-terminal region (His1-Ile5) seems to be flexible also for PACAP27. The extended structures for PACAP21 and PACAP27 reveal that it cannot be ascribed to the nature of peptide-membrane interactions. Furthermore, the dilution of PACAP21 did not change the extended conformation as shown above. The sharp signals strongly suggest that the peptide takes on a well-defined structure in monomers or small oligomers, showing that a high concentration of the peptide is not responsible for the extended structure formation. Therefore, it can be concluded that the interaction of PACAP peptides with the membrane surface causes their extended conformation, which should be ascribed to its amino acid sequence.
A possible origin of the extended conformations for PACAP21 and PACAP27 is fibril formation induced by lipid bilayers. The fibril formation usually needs a certain time for nucleation and elongation. In the case of monosialoganglioside GM1-induced fibril formation, it took 12-20 h [38] . However, PACAP21 and PACAP27 bind liposomes instantly. Furthermore, a dilution of the peptide did not change the conformation. Therefore, a huge fibril formation is not likely, although a short fibril formation on the membrane cannot be eliminated at this stage. Furthermore, we cannot rule out the possibility that PACAP becomes a monomer only at very low concentration, and the monomer takes on an α-helical conformation.
Biological significance of the variable conformation for PACAP27
The structure of micelle-bound PACAP27 comprises a long α-helix (residues 5-27) and a disordered N-terminal tail (residues 1-4) [16] . In the case of the receptor-bound PACAP21 structure, however, there are an extended N-terminal tail (residues 1-2), a consecutive β-turns (residues 3-7) and an α-helix (residues 8-21) [16] . An N-terminally truncated PACAP38 (residues 6-38) takes on α-helix in the receptor [17] . In these cases, the α-helix is the major secondary structure. Therefore, this peptide changes its conformation depending on its environment or interacting partners. Usually, a conformation in micelles is also realized in membranes. However, this is not Tables 1 and 2 were used for calculation. Symbols; red triangle, for observed chemical shifts (δ i ); green circle, for δα i + Δδα i and δβ i − Δδβ i ; and blue square, for δα i − Δδα i and δβ i + Δδβ i . The error bars indicate RMSD for the predicted dihedral angles. Angles with less than 7 reliable pairs are omitted.
the case with PACAP27. Furthermore, many of membranebound peptides reported so far take on α-helices [19, 21] . This is also not the case with PACAP27. Therefore, we can conclude that this hormone peptide has a unique conformational property. A conformational change on membranes was suggested for fusogenic peptide B18, related viral fusogenic peptides [39] and an amyloid precursor protein Aβ [38, 40] . B18 takes on α-helix under lipid/peptide N100, and β-sheets at a higher peptide concentration, which induce membrane-fusion. Aβ(1-40) takes on helix-rich conformations when it binds to monosialoganglioside GM1 bilayers, then forms amyloid fibrils after 12-20 h. These are also the examples that peptides can change their conformations depending on their environments.
It has been indicated that the N-terminal residues are important for the receptor recognition and C-terminal residues facilitate the binding ability. Actually, the deletion of His1-Ile5 caused 200-fold reduction in the binding affinity [41] . The N-terminal regions of both PACAP27 and PACAP21 were shown flexible even on the membrane surface in this work. In contrast, the C-terminal region of PACAP27 was shown to be involved in the membrane binding in the polarization transfer experiment. These properties would be important for PACAP27 to bind the receptor and exert an induced fit on it, provided that membranes are involved in the receptor binding. PACAP27 is known to work in various sites in a wide variety of tissues. Its conformational flexibility may be associated with the variable roles in different places. Actually, an N-terminally truncated neurotensin (residues 8-13) was reported to take on a β-strand in its G-protein coupled receptor bound form [42] .
